Cargando…
Panniculitis Associated with MEK Inhibitor Therapy: An Uncommon Adverse Effect
The combination of MEK inhibitor (cobimetinib, trametinib) and BRAF inhibitor (vemurafenib, dabrafenib) is now the first-line treatment in patients with BRAF V600-mutated metastatic melanoma. This association reduces cutaneous adverse events induced by BRAF inhibitors alone, including photosensitivi...
Autores principales: | Negulescu, Miruna, Deilhes, Florian, Sibaud, Vincent, Tournier, Emilie, Lamant, Laurence, Boulinguez, Serge, Meyer, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465775/ https://www.ncbi.nlm.nih.gov/pubmed/28611627 http://dx.doi.org/10.1159/000461571 |
Ejemplares similares
-
Subcutaneous Panniculitis-like T-Cell Lymphoma with a Transformation to Lupus Erythematosus Panniculitis: A Case Report
por: Tawanwongsri, Weeratian, et al.
Publicado: (2022) -
A Longstanding, Persistent and Recurrent Case of Cryptogenic Panniculitis
por: Pukhalskaya, Tatsiana, et al.
Publicado: (2020) -
Acute Disseminated Panniculitis Associated with Alpha-1 Antitrypsin Deficiency
por: Murinello, António Guilherme, et al.
Publicado: (2022) -
Localized Hypertrichosis with Traumatic Panniculitis: A Case Report and Literature Review
por: Ploydaeng, Monthanat, et al.
Publicado: (2019) -
Necrotizing Panniculitis as an Uncommon Manifestation of Acute Pancreatitis
por: Bruno, Cosimo Marcello, et al.
Publicado: (2017)